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ABSTRACT
The ordered expression of genes after growth factor stimulation in G1
supports the onset of DNA replication. To characterize regulatory events
during S-phase when cell cycle progression has become growth factor
independent, we have profiled the expression of over 7,000 human genes
using GeneChip DNA microarray analysis. HeLa cells were synchronized
at the beginning of S-phase by thymidine/aphidicolin block, and RNA
populations were analyzed throughout the S and G2 phases. Expression of
genes involved in DNA replication is maximal during early S-phase,
whereas histone mRNAs peak at mid S-phase. Genes related to cell
proliferation, including those encoding cyclins, oncoproteins, growth fac-
tors, proteins involved in signal transduction, and DNA repair proteins,
follow distinct temporal patterns of expression that are functionally linked
to initiation of DNA replication and progression through S-phase. The
timing of expression for many genes in tumor-derived HeLa cells is highly
conserved when compared with normal cells. In contrast, a number of
genes show growth phenotype-related expression patterns that may di-
rectly reflect loss of stringent growth control in tumor cells. Our data
reveal there is a core subset of cell growth-related genes that is funda-
mental to cycling cells irrespective of cell growth phenotype.
INTRODUCTION
Cell proliferation is regulated by the intricate interplay of cell
growth regulators, signaling cascades, and mediators of cell cycle
progression including cyclins, cdks,3 tumor suppressors, and onco-
proteins. As cells progress through the cell cycle, functionally distinct
classes of proteins are synthesized and degraded at specific transi-
tions. This cell cycle-dependent turnover and the stage-specific re-
quirements for distinct biochemical activities necessitate a continuous
regulation of RNA and protein levels. Tumor cells exhibit defects in
cell growth control, such as anchorage-independent growth, reduced
growth factor requirements, and increased proliferative potential.
These changes are at least in part mediated by altered activities of
oncoproteins and tumor suppressors. However, mitotic division de-
mands that cells maintain their ordered progression through the cell
cycle. Therefore, we anticipate that there is a fundamental set of genes
with an expression pattern that is conserved between normal and
tumor cells.
Cell cycle control during G1 phase is mediated in part by interac-
tions between retinoblastoma-related tumor suppressor proteins
(p105, p130, and p107; Ref. 1) and the E2 promoter binding factor
(E2F) class of transcription factors (E2F1 to 6; Ref. 2), which are
regulated by the actions of distinct cyclins (cyclins D, E, and A) and
cdks (cdk4/6 and cdk2; Ref. 3–5). Consistent with the important role
of E2F in late G1, many cell growth-regulated genes have E2F binding
sites. However, genes for other cell cycle-regulated proteins whose
expression is up-regulated immediately after G1 (e.g., histones H1,
H2A, H2B, H3, and H4) do not have E2F sites (6). Thus, there may
be multiple gene-regulatory programs involved in the control of
E2F-dependent and -independent genes during the G1 and S phases of
the cell cycle.
During S-phase when the genome is replicated, newly synthesized
DNA is organized into nucleosomes through interactions with histone
proteins. This functional coupling is reflected by the tight linkage
between the timing of DNA synthesis and histone gene expression (6,
7). The elevation of nucleotide pools, necessary to support DNA
synthesis, and histone-dependent packaging of nascent DNA into
nucleosomes are interdependent processes. These processes may very
well be sequentially executed, because accumulation of histone
mRNA and synthesis of histone proteins are only necessary after the
appearance of nascent DNA.
To obtain a genome-wide understanding of the temporal pattern of
gene expression in relation to DNA synthesis, we assessed RNA
populations in cells synchronized at the G1-S-phase transition. Two
principal findings of our study are that: (a) subsets of genes are
successively expressed during the DNA synthesis phase of the cell
cycle; (b) there is a core group of cell growth-related genes that is
required for cell cycle progression in both normal and tumor cells.
MATERIALS AND METHODS
Cell Culture and Cell Cycle Synchronization. HeLa S3 cells were main-
tained at a density of 3  105 cells/ml in minimal essential medium (Life
Technologies, Inc., Rockville, MD), supplemented with 5% calf serum (At-
lanta Biologicals, Norcross, GA), 2% horse serum (Nova-Tech, Inc., Grand
Island, NE), L-glutamine (Sigma Chemical Co., St. Louis, MO), and penicillin/
streptomycin (Sigma). Rapidly dividing HeLa cells were blocked in early
S-phase by a 16-h thymidine block (Sigma), followed by a 10-h release, and a
subsequent 16-h block with aphidicolin (kindly provided by the Drug Synthe-
sis & Chemistry Branch, Developmental Therapeutics Program, Division of
Cancer Treatment and Diagnosis, National Cancer Institute). FACS analyses
were performed to determine cell cycle phase distribution. The rate of DNA
synthesis was determined by [3H]thymidine incorporation as described previ-
ously (8).
Isolation of mRNA and Hybridization Analyses. Total cellular RNA was
isolated with Trizol (Life Technologies, Inc.) and with RNeasy kits (Qiagen,
Valencia, CA) according to the manufacturers’ instructions. RNA was quan-
titated by spectrophotometry (DU640B; Beckman Coulter, Fullerton, CA), and
the quality of the RNA was assessed by electrophoresis in a 1% agarose gel.
Size-fractionated RNA was transferred to a Hybond-N nylon membrane
(Amersham Pharmacia Biotech, Piscataway, NJ) by capillary transfer over-
night. Using [32P]dCTP (NEN) and Rediprime II (Amersham Pharmacia
Biotech), DNA fragments encoding histone H4 (H4,3–2 SK) and GAPDH
(phGAPDH) were labeled, purified, and hybridized to the RNA blots at 42°C.
For microarray analyses, total RNA (5 g) was reverse transcribed into
double-stranded cDNA (SuperScript Choice system; Life Technologies, Inc.)
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with the T7-dT24 primer (Genset Corp., La Jolla, CA). After phenol-chloro-
form extraction, the cDNA was transcribed into biotinylated cRNA (Enzo,
Farmingdale, NY), which was purified (RNeasy; Qiagen) and fragmented
according to the manufacturer’s instructions (Affymetrix Expression Analysis
Technical manual rev. 4, Santa Clara, CA). We used test chips and the HU6800
GeneChip probe arrays and followed the standard hybridization procedures
with the control oligonucleotide B2 (Genset). The arrays were washed in the
Affymetrix GeneChip Fluidics Station 400 and scanned using the Affymetrix
GeneChip array scanner.
Bioinformatic Analyses of Gene Expression. The signals from each mi-
croarray were analyzed, normalized, and converted to a numerical output using
the Affymetrix GeneChip software. The data generated by the different arrays
were globally scaled to the target average intensity of 1500. The average
expression value for each gene across the arrays was used to normalize the
mRNA intensities. Adjusted data were subjected to further analysis using
Xcluster.4 Expression data from two HeLa cell synchronies were analyzed with
Xcluster using log scaling and Pearson’s correlation coefficients to assess the
similarity of expression profiles during the time course, and data were grouped
using the k-means (k  10) and self-organizing map options of Xcluster. Data
were further analyzed by functional groupings, for which we used both
Microsoft Excel and Microsoft Access. The HeLa cell microarray data were
compared with data generated from normal human fibroblasts.5 Several criteria
were used in this comparison: (a) we only included genes that exhibited a
relative level of expression above a threshold (average difference value,
500); (b) expression patterns with values that fluctuated1.5-fold during the
time course were considered constitutive; and (c) to be considered similar
between the two cell types, the peaks or nadirs of the gene expression pattern
should occur within a timeframe of 2 h. For additional information, see our
website.
RESULTS AND DISCUSSION
Genome-wide Expression Profiling Reveals Distinct Gene Reg-
ulatory Programs during the Cell Cycle. We postulate that global
gene-regulatory programs are sequentially expressed during S-phase
to support initiation and progression of chromosome replication. In
addition, temporally and functionally distinct programs may be oper-
ative in the subsequent cell cycle stages to mediate chromosomal
segregation and formation of daughter cells. We analyzed genome-
wide expression patterns using GeneChip microarrays to assess RNA
expression levels during a HeLa cell cycle. We evaluated the microar-
ray data with Affymetrix expression analysis algorithms that monitor
the dataset for the presence or absence of transcripts and determine
their relative expression levels. To validate the accuracy and biolog-
ical relevance of our assays by an independent approach, we per-
formed Northern blot analyses with the same RNA samples used for
the microarray analyses (Fig. 1). We found that the RNA expression
profiles for histone H4, which is a well-established and highly specific
S-phase-related parameter, give quantitatively comparable results
with both methods. The distribution of cells in the cell cycle was
monitored by FACS analyses (Fig. 2A) and reveals that the fraction of
cells in S-phase is proportional to histone gene expression. The FACS
analyses also demonstrate that timepoints chosen reflect enrichment
for cells in early S-phase (1.5 h), mid S-phase (3 h), late S-phase
(4.5–6 h), G2-M phases (6–9 h), and early G1 phase (9 h).
A general overview of microarray data that reveals sequential
expression of groups of genes at different substages of the cell cycle
is provided in Fig. 2B. Analysis of the microarray data indicates that
40% of the genes (2,846) have signal intensities that are signifi-
cantly above background. On the basis of the temporal pattern of
expression during this time course, each gene was assigned to a cluster
by using the k-means clustering algorithm (k  10; Fig. 2B). The
clusters were organized according to their temporal expression pat-
tern, with lower cluster numbers assigned to groups of genes with the
highest expression levels in early S-phase and higher cluster numbers
assigned to groups of genes that peak in G2-M to G1 phase. We found
that many clusters are enriched in genes that correspond with specific,
cell cycle stage-related functions (representative genes are indicated
on the right of Fig. 2B).
The correlation between temporal clusters and functional group-
ings was further assessed by scoring the frequency of occurrence of
distinct groups of genes in each cluster (Table 1). We found several
groups of genes involved in, for example, signal transduction,
protein synthesis, and protein degradation, that are more prevalent
in certain clusters. Inspection of the temporal expression pattern
for each cluster suggests that there are substages during S-phase.
For example, cluster 2 represents genes that are predominantly
expressed in early S-phase, whereas genes in cluster 6 are ex-
pressed at highest levels in mid S-phase (Fig. 3). About half of the
4 Internet address: http://genome-www.stanford.edu/sherlock/cluster.html.
5 Internet address: http://www.salk.edu/docs/labs/chipdata/.
Fig. 1. Northern analyses confirm GeneChip probe array results. A Northern blot of
cellular RNAs from synchronized HeLa cells shows GAPDH and histone H4 mRNA
levels (top panel). The probe sets representing histone H4 for the different experiments are
depicted (lower panel). Each square represents a cell containing millions of oligonucleo-
tides either a perfect match (PM) to the gene or containing a mismatch (MM) in the
sequence. The average of the differences between PM and MM is the value used for
further analyses and corresponds to the mRNA level for a particular gene in a given
sample. The color scheme used (lower panel) ranges from white, red, yellow, green, blue,
and black to indicate the transition from high signal intensities to the absence of signal.
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expressed genes exhibit temporally regulated expression patterns,
in contrast with genes encoding proteins such as cytoplasmic
-actin and most proteasomal proteins, which show barely any
fluctuation. Overall, a succession of gene expression occurs over
time, with particular genes or groups of genes appearing at partic-
ular stages of the cell cycle phases.
If the groups with particular peaks in expression represent distinct
gene-regulatory programs required for either initiation or progression
of chromosome replication, we would expect to find a difference in
the timing of expression for the genes DHFR and histone H4. Indeed,
we found that DHFR and histone H4 are present in different clusters
(Fig. 2B), with DHFR expression increasing before the up-regulation
of histone H4. This finding suggests that there are distinct substages
in S-phase to accommodate biological requirements for the duplica-
tion of the genome.
Induction of Genes Involved in DNA Replication and Early
Response Genes in Early S-Phase. To further elucidate temporal
transitions during S-phase, we examined the genes that are expressed
at the G1-S boundary and the subsequent entry into S-phase. We
addressed whether genes whose expression is up-regulated at early
S-phase are involved in DNA replication and/or in reinitiating prolif-
eration. We found an increase in transcripts for the proteins MCM6,
ORC1, ORC2, and the kinases cdc6 and cdc7 (Fig. 2B, clusters 1 and
3; Fig. 3). These proteins all participate in the initial stages of DNA
replication, which encompass recognition of the origin of replication
and assembly of an initiation complex (10). The subsequent initiation
of DNA synthesis is mediated by DNA primase and DNA polymerase
, followed by DNA polymerase  (11). The corresponding gene
expression patterns for these DNA replication enzymes (shown in Fig.
4A) are comparable with those for genes involved in origin recogni-
tion. Enzymes involved in generating the cellular supply of nucleo-
tides are also expressed in early S-phase (e.g., DHFR in Fig. 2B).
Taken together, many enzymes and proteins involved in DNA syn-
thesis are present in early S-phase.
We found a dramatic increase in the presence of transcripts in-
volved in cell proliferation (see proliferation category in Table 1) in
the group of genes that are maximally expressed at 0–1.5 h after
release (e.g., cluster 2) as well as in gene groups that are expressed at
high levels in subsequent stages. We assessed which specific genes
exhibit high expression in early S-phase. Genes present at release or
up-regulated immediately thereafter included a number of early re-
sponse genes (ATF-3, SRF, ERF-2, IEX-1, and HSP-70), transcrip-
tional regulatory factors (SWI/SNF, ATRX, and others; Ref. 12),
cytokines (MDNCF and BSF-2), nuclear orphan receptors (LXR-,
TR3, Ear-3, and MINOR), and kinases (e.g., c-fes and cdk10; Fig. 3).
Other genes that are induced in early S-phase include those encoding
cell surface proteins, such as cytokine receptors (e.g., frizzled) and
transport-related proteins (e.g., rab13 and TWIK; Table 1). We also
note that there is a moderate increase in metabolic proteins [e.g.,
cyclooxygenase (Cox-2), and acid sphingomyelinase] when the cell
cycle proceeds (Fig. 2B). Therefore, in this early stage of S-phase,
expression of members from several signal transduction pathways as
well as expression of metabolic enzymes is prominent.
Several mRNAs were present at high levels at the G1-S boundary
but exhibited a transient decrease in expression during S-phase.
Among these were envoplakin (a cytoskeletal linker protein), the
growth arrest-specific gene (gas1), the transcription coregulators
Smad1 and Smad6, and BARD1 (Fig. 3). The temporal expression of
these genes may be G1 or G1-S transition specific or correlated with
the synchronization procedure. Thus, there are multiple gene-regula-
tory programs that are initiated in early S-phase, and only a subset
directly supports the onset and progression of DNA replication.
Maximal Expression of Genes Involved in DNA Repair and
Histone Genes Is Linked to Maximal DNA Synthesis. At mid
S-phase, we found a second category of genes that are maximally
expressed when the DNA synthesis rate is highest, which defines this
substage of S-phase. DNA replication may be coupled to mechanisms
that monitor the integrity of nascent DNA. Consistent with this
concept, we found the highest levels of transcripts for proteins in-
volved in DNA repair (e.g., mismatch repair gene) when cells pro-
gress toward mid S-phase (Fig. 2B, clusters 3, 4, and 5). The coordi-
nate up-regulation of histone RNA levels at 4.5–6 h into S-phase (Fig.
2B, cluster 6) accommodates the high demand for core histones (i.e.,
H2A, H2B, H3, and H4; Refs. 7 and 9), which are involved in the
formation of chromatin as DNA is synthesized. Preceding the up-
regulation of these two classes of genes, we find high expression for
Fig. 2. Temporal pattern of expression reveals differences in timing of peak expression
for particular groups of genes during S-phase. A, FACS analyses confirm the synchroni-
zation of the cells. B, shown is a summary bin generated by combining 10 bins (i.e.,
cluster) obtained through k-means clustering. Every horizontal line represents a gene, and
columns are representatives of different timepoints taken, with [] representing samples
generated from log-phase cells. Numbers on the left indicate different clusters. Shown on
the right are particular genes found in different clusters. The yellow color indicates a high
level of expression, black represents no change, and blue indicates the lowest expression
as shown on the bottom. The transition of yellow from the left top to the right bottom of
the bin reflects succession in maximal expression levels.
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several gene regulators involved in chromatin assembly [such as
nuclear protein, ataxia-telangiectasia locus (NPAT) and the chromatin
assembly factor p150 (CAF); Fig. 2B, cluster 3]. Thus, when cells
exhibit peak rates of DNA synthesis, we found maximal expression of
transcripts for proteins that monitor and restore newly replicated DNA
and chromatin.
E2F-dependent versus E2F-independent Gene Regulation. Our
studies indicate that there are temporal differences in RNA expression
Fig. 3. Temporal expression patterns reveal substages in S-phase. Particular groups of genes appear to be highly expressed at particular times throughout the synchrony. Examples
of such genes are given in these plots. G1/S boundary, Smad 1 (Sma and Mad), Smad 6, BARD1 (BRCA1-associated RING domain protein), mcm6 (mini chromosome maintenance
protein), and ORC2 (origin recognition complex). G1/S to Early S phase, cdc6 (cell division cycle protein), Ear-3 (v-erbA-related protein), envoplakin, ribosomal protein L37, LXR-,
and PISSLRE [cyclin-dependent kinase (CDC2-like) 10 (CDK10)]. Early S phase, TR3, MINOR (mitogen-inducible nuclear orphan receptor), HSP70 (heat shock protein 70), SRF
(serum response factor), and c-fes. Mid S phase, MDNCF (monocyte-derived neutrophil chemotactic factor), TGF- (transforming growth factor-), CRABP-II (cellular retinoic
acid-binding protein type II), ALDHIII (aldehyde dehydrogenase), ATF-3 (activating transcription factor 3), and gro- (growth regulated protein ). Mid to Late S phase, MKP-2
(mitogen-activated protein kinase phosphatase 2), pTR7 (repetitive sequence), tubulin-, and PTF  [(PSE)-binding transcription factor]. Late S phase, cyclin A1, Hep27, EPR-1
(effector cell protease receptor-1), and Smad3. G2/M phase, RIG-G (retinoic acid-induced gene G), p55CDC (cdc20), cyclin B, pLK(polo-like kinase), and Ear-2. Early G1 phase, eIF5
(eukaryotic translation initiation factor 5), RCC1 (regulator of chromosome condensation 1), proliferating cell nucleolar antigen, RanBP1 (Ran-binding protein 1), hnRNP1 B1
(heterogeneous nuclear ribonucleoprotein), and CTCF (CCTC-binding factor).
Table 1 Correlation between temporal classes and functional groupings
Upon obtaining the different clusters, the data are organized by function. Occurrence of genes from the different functional groups is counted for each cluster. When comparing
these values with the total number of genes in each cluster, several functional groups of genes appear to be more prevalent in certain clusters (e.g., signal transduction and nuclear
components).
Group
Cluster
1 2 3 4 5 6 7 8 9 10
Genes in the cluster 210 489 224 195 225 202 239 361 295 170
Cell cycle 4 6 4 1 3 1 3 4 4 2
Chromatin 1 2 2 3 8 4 3
Mitotic 11 1 6 2 1 2 1 1
Structural 1 18 3 2 8 1 10 6 2 5
Nuclear 26 42 36 23 28 21 28 64 58 25
DNA replication 2 2 1 2 1 1 2
Transport 1 7 5 5 3 2 1 2 2 1
DNA repair 1 2 3 2 1 1 1
RNA/protein synthesis 2 49 2 0 8 0 17 9 4 3
Signal transduction 32 59 31 19 21 16 37 27 17 16
Kinases 13 36 14 6 11 6 21 13 10 10
Phosphatases 4 9 4 5 3 4 10 0 1 2
Receptors 10 18 11 8 6 5 5 12 2 2
Proliferation 1 18 14 10 15 12 14 15 13 11
Degradation 4 11 2 1 3 5 10 8 5 3
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of proteins involved in DNA synthesis versus transcripts encoding
histone proteins. The first group of transcripts is present at relatively
high levels at the G1-S boundary, whereas the second group does not
peak until at least 1.5 hours into S-phase (Figs. 4, A and B). This
difference in timing is at least in part regulated through transcriptional
mechanisms, as reflected by particular promoter characteristics for the
different groups. The predominant regulatory elements that govern
G1-S-phase-specific expression and corresponding transcription fac-
tors have been identified previously. Of these recognition sequences,
the E2F site is one element critical for the passage through the R point
and G1-S transition, and many genes involved in DNA replication are
E2F responsive (2, 13, 14). Promoters of these genes have at least one
E2F site as well as one or more auxiliary elements (e.g., Sp1 sites) but
in general lack TATA and CCAAT boxes. It is remarkable that
histone gene promoters almost without exception lack E2F sites.
Instead, promoters of the histone gene family are controlled by TATA
and CCAAT boxes, Sp1 sites, and histone subtype-specific elements
(e.g., binding sites for IRF, Oct1, CDP, and HiNF P; Refs. 6 and 9).
Distinctions in promoter organization and gene expression profiles
of DNA replicative genes predict that the cognate transcription factors
may also have differences in expression. The gene expression patterns
of transcription factors that are either known or presumed to interact
with G1-S-phase-related promoter elements (E2F and Sp1 sites,
CCAAT and TATA boxes, and others) were clustered by Pearson’s
correlation and analyzed with k-means (Fig. 4C). The factors we
analyzed appear to separate into three temporally distinct groups.
Three of these genes (i.e., E2F-2, an E2F-like protein, and IRF-5)
have expression patterns resembling those of several DNA poly-
merases (Fig. 4, A and C). A second group of factors [i.e., Sp1, basic
transcription element binding protein (BTEB2), and down-regulator
of transcription 1 (DR1); Refs. 15 and 16] is regulated in parallel with
the histone gene subtypes. Hence, our data suggest that the expression
of at least a subset of transcription factors present in S-phase corre-
lates with the expression of potential downstream target genes.
Transcripts Encoding Protein-modifying Factors and Nuclear
Components Are Temporally Linked with Mitosis. After comple-
tion of S-phase, cells prepare for mitotic division, which requires
condensation, separation, and redistribution of the chromosomes, as
well as major turnover and/or posttranslational modification of pro-
teins. The mitotic phase is preceded by the G2 checkpoint, which is
essential to monitor correct duplication of genetic information, accu-
rate structural formation, and competency for division and completion
of the cell cycle (17). We found maximal expression for several
transcriptional repressors as cells progressed from mid S-phase to
early G1 (e.g., DR1, C/EBP, TGIF, and CTCF; Figs. 3 and 4C),
which may be related to the dramatic decrease in RNA synthesis that
occurs during mitosis (18). We found that transcripts encoding pro-
teins involved in ubiquitination and degradation are present at later
stages of the cell cycle (Table 1, cluster 7). For example, maximal
transcript levels for several genes encoding proteins involved in
protein degradation, such as small SUMO and the cullin proteins
Hs-cul-1 and Hs-cul-4A, were found at 4.5–6 h after release (Fig. 2B).
The increased expression of these protein-inactivating factors indi-
cates that cells have completed S-phase and are preparing for cell
division. Similarly, other enzymes mediating protein modification are
predominantly present in the same temporal cluster (Table 1, cluster
7; e.g., phosphatases and kinases). RNA encoding proteins known to
be involved in mitotic regulation or mitosis are successively expressed
with maximal expression at mid S-phase [e.g., kinesin-like spindle
protein (HKSP) and -tubulin], late S-phase (e.g., cyclin F and PIN1),
or the G2-M phases (e.g., p55cdc and cyclin B; Figs. 2B and 3). We
conclude that several division-specific proteins show an increase in
RNA expression during the mitotic period.
Fig. 4. Differential expression of E2F-dependent and -independent genes at the G1-S
transition. To further distinguish between expression patterns for genes involved in DNA
replication and chromatin assembly, genes of these categories were grouped together, with
one representative bin for genes encoding proteins involved in DNA synthesis (E2F
dependent; A) and one bin for histones (E2F independent; B). Dendrograms indicate
relatedness in expression patterns. C, fluctuations of transcripts for several transcription
factors, which may be involved in the E2F-dependent or -independent expression control,
based on the characteristic promoter elements. The color scheme used is shown in Fig. 2B.
Fig. 5. Summary of gene expression profiles during the cell cycle. Shown is a
representation of the cell cycle, with the light micrographs indicating different cell shapes
and sizes that are prominent at different stages of the cell cycle. The appearance of RNAs
for particular groups of proteins is indicated; maximal expression generally occurs at the
adjacent timepoints.
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The redistribution of chromatin and synthesis of the nuclear enve-
lope in the daughter cells mark the final stage of mitosis and begin-
ning of G1 (20). During these phases, we observed a striking rise in
nuclear proteins (Table 1, clusters 8 and 9). Representative genes
expressed during this transition encoded proteins involved in nuclear
trafficking (e.g., RCC1, RanBP1 and 2, importin , and nucleopore
protein), nuclear structure (e.g., the nuclear matrix protein matrin 3
and lamins A and B), and nucleolar organization (e.g., the proliferat-
ing cell nucleolar antigen; Fig. 3). We found a significant increase in
the majority of RNA-processing factors and translation initiation
factors in early G1. For example, we found that most heterogeneous
nuclear ribonucleoproteins, small nuclear ribonucleoprotein particles,
the nuclear cap binding protein, and translation initiation factors show
peak expression at 9 h (Fig. 2B). In summary, our gene profiling
studies have revealed the sequential expression during S-phase of
RNA encoding proteins such as growth signal-responsive proteins,
proteins involved in DNA synthesis, and proteins involved in chro-
matin assembly (e.g., histones), followed by maximal expression in
the later cell cycle phases of proteins involved in cell division and
nuclear structure (Fig. 5).
Fig. 6. Expression levels for mRNAs of cancer-related proteins show distinct functional and temporal patterns. The proteins shown are selected by their prominent peaks in expression
at particular times during the cell cycle as well as their reported correlation to tumor growth. A, pancreatic mucin, CFR-1 (cystein-rich fibroblast growth factor receptor), c-erb-B-2,
tim1 (21, 22, 24). B, EXTL3 (EXT like protein 3), G0S3 (G0-G1 switch gene 3), pim-1, c-fos, and Tls/Chop (translocation liposarcoma/C/EBP homologous protein; Refs. 23, 25, and
32). C, BTG2 (B-cell translocation gene proteins), DOC-2 (differentially expressed in ovarian carcinoma-2), mda-6 (melanoma differentiation associated protein 6  p21), semaphorin
E, and adrenomedullin (29, 31, 33, 38). D, follistatin, amphiregulin, mda-7 (melanoma differentiation associated protein 7), and semaphorin CD100 (35–37). E, TGIF (5TG3	
interacting factor), annexin II, CaSm (cancer-associated Sm-like oncoprotein), and BMI-1 (27, 28, 30). F, Abl, GRK5 (G protein-coupled receptor kinase-5), calcineurin A1, SHIP
(SH2-containing inositol phosphatase), and S100A2 (39–41). The graphs show maximal RNA expression of signal transduction molecules in early S-phase, proteins involved in cell
growth and tumor malignancy from mid to late S-phase, and potential signal transduction attenuators during G2-M.
Table 2 Comparison of gene expression in two cell types by functional groupings.
Group
Expressed in
Both cell types Primary fibroblast HeLa tumor cell
Number of genes 1837 1091 987
Cell cycle 19 2 6
Chromatin 12 0 13
Mitotic 12 0 7
Structural 123 43 31
Nuclear 246 49 137
DNA replication 10 1 2
Transport 29 20 18
DNA repair 12 2 1
RNA/protein synthesis 68 1 7
Signal transduction 180 96 116
Kinases 87 24 51
Phosphatases 26 8 14
Receptors 67 64 51
Proliferation 94 28 40
Degradation 22 1 5
The data obtained from the two microarray assays are organized by function for cell
type-specific expression as well as conserved expression. Occurrence of genes from the
different functional groups is scored. Genes from groups like Receptors and Transport
show little similarities between the two cell types. In contrast, the groups Cell cycle, DNA
replication, DNA repair, RNA/protein synthesis and Degradation contain mostly genes
that are expressed in both the tumor-related HeLa cells and the normal fibroblasts.
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Table 3 Comparison of microarray data from HeLa tumor-related cells with cell cycle data from normal fibroblasts reveals a highly conserved subset of genes
ID Name Description
A. Genes with similar cell cycle-related expression patterns in normal fibroblasts and tumor-related HeLa cells
Cell cycle
X54942 CKS1 CDC28 protein kinase 2
X05360 CDC2 Cell division cycle 2
U05340 CDC20 Cell division cycle 20, Saccharomyces cerevisiae homologue
L22005 CDC34 Cell division cycle 34
U14518 CENPA Centromere protein A (17kD)
X51688 CCNA2 Cyclin A
M25753 CCNB1 Cyclin B1
Z36714 CCNF Cyclin F
X80230 CDK9 Cyclin-dependent kinase 9 (CDC2-related kinase)
U40343 CDKN2D Cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)
M13194 ERCC1 Excision repair cross-complementing rodent repair deficiency
D64142 H1FX H1 histone family, member X
X14850 H2AFX H2A histone family, member X
X60486 H4FG H4 histone family, member G
J05614 PCNA Human proliferating cell nuclear antigen (PCNA) gene
D26361 KIAA0042 Kinesin superfamily member DUnc 104
U37426 KNSL1 Kinesin-like 1
X67155 KNSL5 Kinesin-like 5 (mitotic kinesin-like protein 1)
D84557 MCM6 Minichromosome maintenance deficient (mis 5, Schizosaccharomyces pombe) 6
D21063 MCM2 Minichromosome maintenance deficient (Saccharomyces cerevisiae) 2 (mitotin)
D38073 MCM3 Minichromosome maintenance deficient (Saccharomyces cerevisiae) 3
U01038 PLK Polo (Drosophila)-like kinase
D38551 RAD21 RAD21 (S. pombe) homologue
M87339 RFC4 Replication factor C (activator 1) 4 (37kD)
M91670 E2-EPF Ubiquitin carrier protein
U73379 UBCH10 Ubiquitin carrier protein E2-C
U58090 Hs-cul-4A
Signaling
X89985 BCL7B B-cell CLL/lymphoma 7B
U72066 CtIP CtBP interacting protein CtIP
M60278 DTR Diphtheria toxin receptor
U15932 DUSP5 Dual specificity phosphatase 5
L38487 ESRRA Estrogen-related receptor 
U18018 ETV4 ets variant gene 4 (E1A enhancer-binding protein, E1AF)
U80947 Glucocorticoid receptor
U75679 HBP Hairpin binding protein, histone
S81914 IER3 Immediate-early response 3
X69111 ID3 Inhibitor of DNA binding 3, dominant-negative helix-loop-helix protein
X58377 IL11 Interleukin 11
U56816 PKMYT1 Tyrosine- and threonine-specific cdc2-inhibitory kinase
X60188 MAPK3 Mitogen-activated protein kinase 3
X80692 MAPK6 Mitogen-activated protein kinase 6
L08246 MCL1 Myeloid cell leukemia sequence 1 (BCL2-related)
D87953 NDRG1 N-myc downstream regulated
U90426 DDXL Nuclear RNA helicase, DECD variant of DEAD box family
U33053 PRKCL1 Protein kinase C-like 1
U47077 PRKDC Protein kinase, DNA-activated, catalytic polypeptide
X89750 TGIF TG-interacting factor (TALE family homeobox)
M86699 TTK TTK protein kinase
U20647 ZNF151 Zinc finger protein 151 (pHZ-67)
Miscellaneous
M91029 AMPD2 Adenosine monophosphate deaminase 2 (isoform L)
X76228 ATP6E ATPase, H transporting, lysosomal (vacuolar proton pump)
M94345 CAPG Capping protein (actin filament), gelsolin-like
U81556 OS4 Conserved gene amplified in osteosarcoma
U55206 GGH -Glutamyl hydrolase
D14686 Glycine cleavage system T-protein
X62691 Homo sapiens mRNA for ribosomal protein
L37368 Human (clone E5.1) RNA-binding protein mRNA
X12458 Human P3 gene
X76771 PMP22 Human peripheral myelin protein-22 (PMP22) gene
L42572 IMMT Inner membrane protein, mitochondrial (mitofilin)
U28386 KPNA2 Karyopherin 2 (RAG cohort 1, importin 1)
M61916 LAMB1 Laminin, 1
X82895 MPP2 Membrane protein, palmitoylated 2
J04031 MTHFD1 Methylenetetrahydrofolate dehydrogenase
X07315 PP15 Nuclear transport factor 2 (placental protein 15)
U59752 PSCD2 Pleckstrin homology, Sec 7 and coiled/coil domains 2
U53204 PLEC1 Plectin 1, intermediate filament binding protein, 500kD
X78136 PCBP2 Poly(rC)-binding protein 2
U04636 PTGS2 Prostaglandin-endoperoxide synthase 2
X55954 RPL23 Ribosomal protein L23
L19527 RPL27 Ribosomal protein L27
U46751 SOSTM1 Sequestosome 1
X99585 SMT3H2 SMT3 (suppressor of mif two 3, yeast) homologue 2
U81375 SLC29A1 Solute carrier family 29 (nucleoside transporters)
J04611 G22P1 Thyroid autoantigen 70kD (Ku antigen)
M90657 TMF4SF1 Transmembrane 4 superfamily member 1
U04810 TROAP Trophinin-associated protein (tastin)
M19714 Tropomyosin, 
X89398 UNG Uracil-DNA glycosylase
D13633 KIAA0008
D31885 KIAA0069
D43948 KIAA0097
a The results presented in this study with tumor cells are compared with those generated by a synchrony of normal diploid cells (19).5 Genes that are expressed in both studies are
listed. Grouped together are: (A) genes with similar cell cycle-related expression patterns (conserved), (B) genes that are expressed in both cell lines but with altered expression patterns
(different, constitutive, or not determined), or (C) genes that are expressed in the normal fibroblast yet are not detected the HeLa cancer-related cell line (absent).
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Expression Patterns for Genes with Cancer-related Properties.
Our microarray analyses have established that there are substages in
S-phase with distinct gene expression programs. Because HeLa cells
are derived from a cervical carcinoma, we evaluated the presence of
cancer-related and cell growth-regulatory genes in our dataset and
analyzed their expression patterns in relation to S-phase substages
(Fig. 6). In early S-phase, we found high expression of cytokine
receptors involved in tumor proliferation (21, 22), as well as a number
of oncoproteins (23–26). These expression patterns parallel the in-
creased expression of transcripts encoding other cell signaling-related
proteins that are maximally expressed in early S-phase (see Fig. 3). At
mid to late S-phase, we observed peak expression for several genes
encoding proteins with mitogenic properties that are involved in
metastasis (27), maintenance of the transformed phenotype (28), or
induction of proliferation (29, 30). We also found increased expres-
sion of genes encoding several tumor suppressor proteins or proteins
with antiproliferative properties. Thus, although many proteins with
oncogenic properties are expressed from mid to late S-phase, a similar
peak of expression occurs for numerous growth inhibitors and tumor
suppressors (31–38). From late S-phase to G2-M, we found enhanced
expression of several genes encoding proteins involved in calcium and
inositol signaling. Moreover, some of these proteins have also been
associated with negative effects on cell growth and/or involvement in
apoptosis (39–41). Hence, we have characterized expression of signal
transduction molecules in early S-phase, proteins involved in cell
growth and tumor-related proteins from mid to late S-phase, and
potential signal transduction attenuators during G2-M.
To assess whether the cancer-related genes described above play a
Table 3 Continued
ID Name Description
B. Genes expressed in normal fibroblasts and HeLa cells but with different cell cycle-related expression patternsa
Different
D16562 CAST ATP synthase
X54941 CKS1 CDC28 protein kinase 1
X55740 cDNA coding for 5 nucleotidase (EC 3.1,3.5)
X96753 CSPG4 Chondroitin sulfate proteoglycan 4
U09579 p21/Cip1 Cyclin-dependent kinase inhibitor 1A (p21)
X06256 Fibronectin receptor  subunit
M23379 RASA1 GTPase-activating protein ras p21 (RASA)
L28010 HnRNP F Heterogeneous nuclear ribonucleoprotein H
U47105 Human H105e3 mRNA
X81788 ICT1 Immature colon carcinoma transcript 1
M22919 MLC gene (non-muscle myosin light chain)
X92720 PCK2 Phosphoenolpyruvate carboxykinase
Y00971 PRPS2 Phosphoribosyl pyrophosphate synthetase 2
D84110 RBP-MS/ty RNA-binding protein gene with multiple splicing
J03161 SRF Serum response factor
J05243 SPTAN1 Spectrin, 
Constitutive
D90209 ATF4 Activating transcription factor 4
AF006084 ARPC1B Arp2/3 protein complex subunit p41-Arc (ARC41)
D16217 CAST Calpastatin
M55268 CSNK2A2 Casein kinase 2
X52142 CTP A CTP synthase
X66364 CDK5 Cyclin-dependent kinase 5
U53446 DAB2 Disabled homologue 2 (mitogen responsive)
U10362 GP36B Endoplasmic reticulum glycoprotein
M62994 FLNB Filamin B
U74612 FOXM1 Forkhead boxM1
L37033 FKHR Forkhead domain protein
U46023 Xq28 Gene mutated in X-linked myotubular myopathy
U10860 Guanosine 5	-monophosphate synthase
M94630 HNRPD Heterogeneous nuclear ribonucleoprotein D
X53586 Integrin  6
X51345 JUNB junB proto-oncogene
D23673 KIAA0864 KIAA0864
U63743 KNSL6 Kinesin-like 6
Y00764 Mitochondrial hinge protein
Z24725 MIG2 Mitogen inducible 2
Z97054 SMC1 Mitosis-specific chromosome segregation protein
M69066 MSN Moesin
U02493 NONO Non-Pou domain-containing octamer binding protein
X12492 NFIC Nuclear factor I/C (CCAAT-binding TF)
HG3415-HT3598 at Poliovirus receptor
L76517 PSEN1 Presenilin 1
M77836 PYCR1 Pyrroline-5-carboxylase,  polypeptide
L19527 RPL27 Ribosomal protein L27
D38555 SEC24C SEC24C
U18543 Zinc-finger protein mRNA
Not determined
M19645 78-kDa glucose-regulated protein (GRP78)
X53416 filamin Actin-binding protein
U33286 CAS Chromosome segregation gene homologue
L35240 Enigma gene
K03195 HepG2 Glucose transporter gene
L12723 hsp70 Heat shock protein 70
D50405 RPD3L1 Homologous to RPD3, a transcription factor in Saccharomyces cerevisiae
D79997 KIAA0175 KIAA0175
U14391 Myosin-IC
M95178 Non-muscle -actinin
X79439 Notch 3
U24152 PAK1 p21/Cdc42/Rac1-activated kinase 1
X70476 Subunit of coatomer complex
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Table 3 Continued
ID Name Description
C. Genes that are expressed in normal fibroblasts but not detected in HeLa tumor-related cells
Cell cycle
L47276 -Topoisomerase truncated form
X59798 CCND1 Cyclin D1 (PRAD1: parathyroid adenomatosis 1)
M60974 GADD45A Growth arrest and DNA-damage-inducible, 
U28749 HMGIC High-mobility group protein isoform I-C
X85137 KNSL1 Kinesin-like 1
X62153 MCM3 Minichromosome maintenance deficient (Saccharomyces cerevisiae) 3
X74331 PRIM2A Primase, polypeptide 2A (58kD)
J04088 TOP2A Topoisomerase (DNA) II  (170kD)
Signaling
X84213 BAK1 BCL2-antagonist/killer 1
X52541 EGR1 Early growth response 1
L26336 HSPA2 Heat shock 70kD protein 2
M63838 IFI16 Interferon, -inducible protein 16
X04602 IL6 Interleukin 6 (interferon, beta 2)
U20734 JUNB junB proto-oncogene
S57212 MEF2C MADS box transcription enhancer factor 2, polypeptide C
M12174 ARHB ras homologue gene family, member B
S82240 ARHE ras homologue gene family, member E
U27655 RGS3 Regulator of G-protein signalling 3
U27768 RGS4 Regulator of G-protein signalling 4
X82877 RSC1A1 Regulatory solute carrier protein, family 1, member 1
U72206 ARHGEF2 rho/rac guanine nucleotide exchange factor (GEF) 2
D43968 RUNX1 runt-related transcription factor 1 (oncogene)
X64652 Mssp-1 Single-stranded DNA-binding protein
U14134 Transcription factor IIIa
X66087 MYBL1 v-myb avian myeloblastosis viral oncogene homologue-like 1
M92843 ZFP36 Zinc finger protein homologous to Zfp-36 in mouse
Miscellaneous
M19650 CNP 2	,3	-Cyclic nucleotide 3	 phosphodiesterase
M36430 ARF1 ADP-ribosylation factor 1
M57763 ARF6 ADP-ribosylation factor 6
M80899 AHNAK AHNAK nucleoprotein (desmoyokin)
L42563 ATPALI ATPase, Na/K transporting,  polypeptide-like 1
HG2290-HT2386_at Calcitonin
M19311 CALM2 Calmodulin 2 (phosphorylase kinase, )
M30448 CSNK2B Casein kinase 2,  polypeptide
U13737 CASP3 Caspase 3, apoptosis-related cysteine protease
U32114 Caveolin-2 mRNA
X03934 CD3D CD3D antigen,  polypeptide (TiT3 complex)
M23323 CD3E CD3E antigen,  polypeptide (TiT3 complex)
U76764 CD97 CD97 antigen
M27436 F3 Coagulation factor III (thromboplastin, tissue factor)
X15880 COL6A1 Collagen, type VI, 1
X52022 COL6A3 Collagen, type VI, 3
D26535 DLST Dihydrolipoamide S-succinyltransferase
U53445 DOC1 Down-regulated in ovarian cancer 1
U00802 DBN1 Drebin 1
U14187 EFNA3 Ephrin-A3
U43916 EMP1 Epithelial membrane protein 1
M24485 GSTP1 Glutathione S-transferase 
L38503 GSTT2 Glutathione S-transferase  2
X79537 Glycogenin
X76942 GOLGA4 Golgi autoantigen, golgin subfamily a, 4
M65028 hnRNP A/E Heterogeneous nuclear ribonucleoprotein A/B
D16593 HPCA1 Hippocalcin
U54804 HAS2 Hyaluron synthase
U29343 HMMR Hyaluronan-mediated motility receptor (RHAMM)
L41919 HIC1 Hypermethylated in cancer 1
X57809 IGL Immunoglobulin 	 locus
X90763 KRTHA5 Keratin, hair, acidic, 5
D31764 KIAA0064 KIAA0064 gene product
D50925 KIAA0135 KIAA0135 protein
X79683 LAMB2 Laminin,  2 (laminin S)
U65416 MICB MHC class I polypeptide-related sequence B
J02854 MYRL2 Myosin regulatory light chain 2, smooth muscle isoform
M94167 NRG1 Neuregulin 1
D86425 NID2 Nidogen 2
U24183 PFKM Phosphofructokinase, muscle
K03021 PLAT Plasminogen activator, tissue
U09937 PLAUR Plasminogen activator, urokinase receptor
M21574 PDGFRA Platelet-derived growth factor receptor,  polypeptide
Z11585 Potassium channel protein (Gb:Z11585)
U25988 PSG11 Pregnancy-specific -1-glycoprotein 11
D28235 PTGS2 Prostaglandin-endoperoxide synthase 2
U19948 PDI Protein disulfide isomerase
X17042 PRG1 Proteoglycan core protein
X14684 SSB Sjo¨gren syndrome antigen B (autoantigen La)
U19495 SDF1 Stromal cell-derived factor 1
D79984 SUPT6H Suppressor of Ty (Saccharomyces cerevisiae) 6 homologue
M32304 TIMP2 Tissue inhibitor of metalloproteinase 2
M99439 TLF4 Transducin-like enhancer of split 4, homologue of Drosophila E(sp1)
M55153 TGM2 Transglutaminase 2
D78577 YWHAH Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein
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role in aberrant cell growth, we compared our results with gene
expression data obtained from diploid fibroblasts synchronized in
S-phase (19).6 The majority of the transcripts, encoding oncoproteins,
proliferation-inducing proteins, and potential signal transduction at-
tenuators, were not expressed in normal cells, suggesting a role in
tumor growth. Most of those genes that were expressed in normal cells
exhibited differences in temporal expression patterns between normal
and tumor cells, such as elevated expression levels or loss of fluctu-
ation.7 These data reveal that the timing of the maximal expression of
cancer-related genes is specific for particular cell cycle stages. Our
findings are consistent with potential roles for these proteins in the
regulation of cell cycle progression or in the timing of certain tumor-
related processes during the cell cycle.
Comparison of Normal and Tumor Cells Revealed a Core
Group of Cell Growth-related Genes. Gene expression analysis for
synchronized normal fibroblasts has been presented (19) using the
same type of microarrays. To evaluate the similarities and differences
in gene expression in normal and tumor cells, we analyzed the global
expression data from the two studies. The results of this comparison
reveal that two-thirds (i.e., 1,837) of the total number of genes
expressed in HeLa cells are also expressed in normal fibroblasts and
vice versa. A large number of genes exhibit higher expression levels
in the cancer cell and often lose their cell cycle-related pattern. This
group mostly included transcription factors, structural proteins, and
several proteins involved in the process of chromosomal segregation.
We scored the occurrence of genes in several functional groups and
compiled the results (Table 2). Two groups (Receptors and Transport)
include many genes that exhibit cell type-specific expression and may
represent phenotypic markers. In contrast, genes in five groups (i.e.,
Cell cycle, DNA replication, DNA repair, RNA/protein synthesis, and
Degradation) are expressed in both normal and tumor cells. Thus,
despite significant phenotypic differences in the cell types, there is a
striking conservation in the expression of multiple functional classes
of genes. For additional information, see our website.
We further compared the two datasets to identify genes involved
in the cell cycle for which expression patterns are conserved, genes
for which patterns are altered, and genes that are not expressed in
the cancer cell. Of the 222 cell cycle genes identified in the human
diploid fibroblast study, 81 genes (36%) are expressed below the
level of detection in the tumor cell cycle. The most pronounced
difference is that several RNAs for proteins involved in cell
adhesion and cell structure are not expressed in the HeLa tumor
cell, as well as many genes encoding signaling molecules. There-
fore, the differences between normal and tumor cells with respect
to cell structure and growth characteristics are reflected by gene
expression profiles.
In contrast to these genes that are not expressed, the group of
cell cycle-regulated genes identified in the diploid fibroblast cells
contains 141 (64%) genes that were also expressed in the synchro-
nized HeLa cells. Table 3 provides an overview of the similarities
and differences in the expression patterns of cell cycle-specific
genes identified in the two studies. The data reveal that the
expression patterns for many genes (45 of 141) are different, and
most of these genes are constitutively expressed in the tumor cell
line (for example, transcription factors and genes involved in
mitosis; see Fig. 7). Only a limited number of genes exhibited
temporal expression patterns in the cancer cells that were fluctu-
ating yet different from those in the normal cell type. Among these
genes were the tumor repressor p21, the transcription factor serum
response factor, the protein spectrin (involved in cell shape), and
metabolic proteins such as ATP synthase (Table 3 and Fig. 7).
Thus, although a number of genes show alterations in the temporal
regulation of RNA levels, the expression of the majority of this
subgroup of genes is no longer cell cycle regulated.
The expression patterns of the remaining genes (82 of 141)
exhibit similar fluctuations in expression during the cell cycle.
Many genes that display cell cycle-controlled expression are key
cell cycle regulatory factors, including kinesins, MCMs, histones,
replication factor C, and several cyclins and cdcs (Table 3 and Fig.
7). Hence, a relatively small fraction (37%) of the genes that are
cell cycle regulated in the diploid fibroblast cell type are also
expressed and similarly modulated during the tumor cell cycle.
These genes may constitute a core set of regulatory genes funda-
mental to cell cycle progression.
In conclusion, in this study we have characterized the sequential
expression of genes that regulate or mediate genome replication. We
identified groups of genes that are maximally expressed at specific
substages during S-phase and G2. These genes encode cell growth
and/or cancer-related proteins that may play specific roles at critical
cell cycle transitions. We propose that the classically defined S and G2
phases of the cell cycle can be subdivided into distinct substages
based on diagnostic gene expression profiles. The second principal
finding that emerged from our studies is the identification of a core set
of genes that is similarly regulated in both normal and tumor cells and
6 Internet address: http://www.salk.edu/docs/labs/chipdata/primary.html.
7 For additional information, see our web site: http://www.umassmed.edu/cellbio/labs/
steinlab.
Fig. 7. Examples of differences in expression patterns between normal and tumor cells.
A, cyclin B1 and kinesin-like 5 genes are examples of two genes with similar cell cycle
related expression patterns in both cell types. B, jun B and moesin are two genes that
exhibit cell cycle-related fluctuations in expression pattern, yet are constitutively ex-
pressed in the HeLa cell cycle. C, Spectrin, SRF, ATP synthase, and p21CIP1 are all
expressed with cell cycle-related fluctuations in both cell types, which are not similar.
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may support the fundamental mechanisms required for cell cycle
progression.
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